Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company BioAtla LLC
DescriptionConditionally active biologic (CAB) targeting AXL receptor tyrosine kinase (AXL; UFO)
Molecular Target AXL receptor tyrosine kinase (AXL) (UFO)
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today